2004Journal of the Korean Medical AssociationOpen access

Treatment of Obesity with Drugs

Sang Man Kim

Open full text 3 citations

Abstract

Treatment of Obesity with DrugsO besity is a major global health problem.However, current therapeutic strategies for obesity are limited.Obesity results from an imbalance between energy intake and energy expenditure, and the treatment of obesity is based on the correction of this metabolic imbalance.Anti-obesity drugs can shift this balance in a favorable way by reducing food intake, altering metabolism, and by increasing energy expenditure.There is a growing consensus that pharmacotherapy is appropriate for many individuals who are unable to lose weight through less intensive measures.However, side effects may ensue phamacotherapy for obesity.Only two drugs (sibutramine and orlistat) are currently approved for the long-term treatment of obesity.Sibutramine inhibits the reuptake of serotonin and norepinephrine.Orlistat works by blocking the pancreatic lipase.However, phamarcotherapy may not be the ultimate resolution for obesity management.Because the underlying pathophysiology in each individual varies in many aspects, it is recommended to provide individualized and tailored medication in addition to other anti-obesity supportive treatments.

Open-access reader

About this research paper

What this paper is about

Treatment of Obesity with DrugsO besity is a major global health problem.However, current therapeutic strategies for obesity are limited.Obesity results from an imbalance between energy intake and energy expenditure, and the treatment of obesity is based on the correction of this metabolic imbalance.Anti-obesity drugs can shift this balance in a favorable way by reducing food intake, altering metabolism, and by increasing energy expenditure.There is a growing consensus that pharmacotherapy is appropriate for many individuals who are unable to lose weight through less intensive measures.However, side effects may ensue phamacotherapy for obesity.Only two drugs (sibutramine and orlistat) are currently approved for the long-term treatment of obesity.Sibutramine inhibits the reuptake of serotonin and norepinephrine.Orlistat works by blocking the pancreatic lipase.However, phamarcotherapy may not be the ultimate resolution for obesity management.Because the underlying pathophysiology in each individual varies in many aspects, it is recommended to provide individualized and tailored medication in addition to other anti-obesity supportive treatments.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Treatment of Obesity with DrugsO besity is a major global health problem.However, current therapeutic strategies for obesity are limited.Obesity results from an imbalance between energy intake and energy expenditure, and the treatment of obesity is based on the correction of this metabolic imbalance.Anti-obesity drugs can shift this balance in a favorable way by reducing food intake, altering metabolism, and by increasing energy expenditure.There is a growing consensus that pharmacotherapy is appropriate for many individuals who are unable to lose weight through less intensive measures.However, side effects may ensue phamacotherapy for obesity.Only two drugs (sibutramine and orlistat) are currently approved for the long-term treatment of obesity.Sibutramine inhibits the reuptake of serotonin and norepinephrine.Orlistat works by blocking the pancreatic lipase.However, phamarcotherapy may not be the ultimate resolution for obesity management.Because the underlying pathophysiology in each individual varies in many aspects, it is recommended to provide individualized and tailored medication in addition to other anti-obesity supportive treatments.

Key concepts: Orlistat, Sibutramine, Obesity, Medicine, Management of obesity, Pharmacotherapy, Reuptake, Weight loss

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of Obesity with Drugs — Research Paper | ScholarLens